Humana Inc.

HUM Healthcare Healthcare Plans

Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024. In the quarter to June 2026, revenue grew 26.2%, EPS grew 27.9%, free cash flow grew 58.5% and total debt rose 13.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

413.16 19.04 −4.41%
Market cap
$51.9B
P/E
38.8×
Fwd P/E
42.9×
Dividend yield
0.86%
F-score
6/9
Altman Z
4.66
Beneish M
−2.29
Dividend safety
61/100

Humana Inc. (HUM) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Humana Inc. (HUM) trades at a EV/Sales of 0.3×. Over the past ten years it has ranged from 0.1× (March 2026) to 0.7× (November 2018); the current reading is higher than 18% of that period. That is below the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 0.2× (0.81%)
FY2024 0.2× (59.31%)
FY2023 0.5× (23.53%)
FY2022 0.6× (10.80%)
FY2021 0.7× 18.27%
FY2020 0.6× (7.67%)
FY2019 0.6× 5.44%
FY2018 0.6× 12.94%
FY2017 0.5× 26.46%
FY2016 0.4× 5.58%

Quarterly newest first

Period EV/Sales Change
Jun 2026 0.3× 177.98%
Mar 2026 0.1× (49.00%)
Dec 2025 0.2× 4.18%
Sep 2025 0.2× 4.06%
42 more quarters

Against its own ten years

Low 0.1× High 0.7×
Ten-year median 0.4×
Current reading's percentile 20

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on HUM